{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T06:51:15Z","timestamp":1794034275575,"version":"4.8.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ijantimicag.2015.08.006","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T23:51:26Z","timestamp":1442015486000},"page":"586-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["A role for fosfomycin treatment in children for prevention of haemolytic\u2013uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection"],"prefix":"10.1016","volume":"46","author":[{"given":"Hitoshi","family":"Tajiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Ushijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ishige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0080","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM198303243081203","article-title":"Hemorrhagic colitis associated with a rare Escherichia coli serotype","volume":"308","author":"Riley","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0085","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-109-9-705","article-title":"Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum","volume":"109","author":"Griffin","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/S0950268800050627","article-title":"Diarrhoea in close contacts as a risk factor for childhood haemolytic uraemic syndrome. The CPKDRC co-investigators","volume":"110","author":"Rowe","year":"1993","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0095","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/cid\/cis299","article-title":"Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis","volume":"55","author":"Wong","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/INF.0b013e31823096a8","article-title":"Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota","volume":"31","author":"Smith","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0110","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s100960050181","article-title":"Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents","volume":"17","author":"Grif","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0115","first-page":"357","article-title":"Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection","volume":"52","author":"Ikeda","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0120","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.288.8.996","article-title":"Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis","volume":"288","author":"Safdar","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3476(05)81209-0","article-title":"Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis","volume":"121","author":"Proulx","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0130","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-3476(05)81600-2","article-title":"Hemolytic\u2013uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations","volume":"116","author":"Pavia","year":"1990","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0135","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(05)81609-9","article-title":"Risk factors for the progression of Escherichia coli O157:H7 enteritis to haemolytic\u2013uremic syndrome","volume":"116","author":"Cimolai","year":"1990","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1574-695X.1997.tb01072.x","article-title":"Effect of antimicrobial agents, especially fosfomycin, on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157:H7","volume":"19","author":"Yoh","year":"1997","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-2180-12-160","article-title":"Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak","volume":"12","author":"Corogeanu","year":"2012","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.08.006_bib0150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-119-3-199308010-00025","article-title":"The haemolytic\u2013uremic syndrome and Escherichia coli O157:H7 infection","volume":"119","author":"Robson","year":"1993","journal-title":"Ann Intern Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915002976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915002976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T13:57:52Z","timestamp":1537365472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915002976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0924857915002976"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.08.006","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A role for fosfomycin treatment in children for prevention of haemolytic\u2013uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}